Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors
- PMID: 14963129
- PMCID: PMC369213
- DOI: 10.1128/jvi.78.5.2327-2335.2004
Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors
Abstract
Retroviral vectors based on foamy viruses (FV) are efficient gene delivery vehicles for therapeutic and research applications. While previous studies have shown that FV vectors transduce quiescent cell cultures more efficiently than oncoviral vectors, their specific cell cycle requirements have not been determined. Here we compare the transduction frequencies of FV vectors with those of onco- and lentiviral vectors in nondividing and dividing normal human fibroblasts by several methods. FV vectors transduced serum-deprived fibroblast cultures more efficiently than oncoretroviral vectors and at rates comparable to those of lentiviral vectors. However, in these cultures FV vectors only transduced a subpopulation of proliferating cells, as determined by bromodeoxyuridine staining for DNA synthesis. In contrast to lentiviral vectors, FV vectors were unable to transduce human fibroblasts arrested by aphidicolin (G(1)/S phase) or gamma-irradiation (G(2) phase), and a partial cell cycle that included mitosis but not DNA synthesis was required. We could not determine if mitosis facilitated nuclear entry of FV vectors, since cell-free vector preparations contained long terminal repeat circles, precluding their use as nuclear markers. In contrast to oncoviral vectors, both FV and lentiviral vectors efficiently transduced G(0) fibroblasts that were later stimulated to divide. In the case of FV vectors, this was due to the persistence of a stable transduction intermediate in quiescent cells. Our findings support the use of FV vectors as a safe and effective alternative to lentiviral vectors for ex vivo transduction of stem cells that are quiescent during culture but divide following transplantation.
Figures
Similar articles
-
In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.J Virol. 2002 Feb;76(3):1496-504. doi: 10.1128/jvi.76.3.1496-1504.2002. J Virol. 2002. PMID: 11773422 Free PMC article.
-
The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.Virology. 2001 Feb 15;280(2):243-52. doi: 10.1006/viro.2000.0773. Virology. 2001. PMID: 11162838
-
Foamy virus as a gene transfer vector to the central nervous system.Gene Ther. 2009 Mar;16(3):448-52. doi: 10.1038/gt.2008.171. Epub 2008 Dec 4. Gene Ther. 2009. PMID: 19052632 Free PMC article.
-
Large animal models for foamy virus vector gene therapy.Viruses. 2012 Dec 7;4(12):3572-88. doi: 10.3390/v4123572. Viruses. 2012. PMID: 23223198 Free PMC article. Review.
-
Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.Curr Gene Ther. 2007 Aug;7(4):261-71. doi: 10.2174/156652307781369092. Curr Gene Ther. 2007. PMID: 17969559 Review.
Cited by
-
Nonintegrating foamy virus vectors.J Virol. 2010 Sep;84(18):9341-9. doi: 10.1128/JVI.00394-10. Epub 2010 Jun 30. J Virol. 2010. PMID: 20592072 Free PMC article.
-
Optimization of lentiviral vector production using polyethylenimine-mediated transfection.Oncol Lett. 2015 Jan;9(1):55-62. doi: 10.3892/ol.2014.2684. Epub 2014 Nov 7. Oncol Lett. 2015. PMID: 25435933 Free PMC article.
-
Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.Mol Ther. 2013 May;21(5):964-72. doi: 10.1038/mt.2013.34. Epub 2013 Mar 26. Mol Ther. 2013. PMID: 23531552 Free PMC article.
-
Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.PLoS Pathog. 2016 Aug 31;12(8):e1005860. doi: 10.1371/journal.ppat.1005860. eCollection 2016 Aug. PLoS Pathog. 2016. PMID: 27579920 Free PMC article.
-
In vivo selection of hematopoietic stem cells transduced at a low multiplicity-of-infection with a foamy viral MGMT(P140K) vector.Exp Hematol. 2008 Mar;36(3):283-92. doi: 10.1016/j.exphem.2007.11.009. Exp Hematol. 2008. PMID: 18279716 Free PMC article.
References
-
- Alexander, I. E., D. W. Russell, and A. D. Miller. 1997. Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum. Gene Ther. 8:1911-1920. - PubMed
-
- Bieniasz, P. D., O. Erlwein, A. Aguzzi, A. Rethwilm, and M. O. McClure. 1997. Gene transfer using replication-defective human foamy virus vectors. Virology 235:65-72. - PubMed
-
- Brown, P., G. Nemo, and D. C. Gajdusek. 1978. Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses. J. Infect. Dis. 137:421-427. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials